“…Most of these can combine to form heterooligomers, resulting in altered pharmacological properties. The eight subtypes of P2Y receptors (P2Y 1,2,4,6,11,12,13,14 ) are activated by ATP, ADP, UTP, UDP, or nucleotide sugars, depending on the subtype, and couple to differential intracellular signaling pathways [104]. In rodents, the most common experimental animals, the ligand preference (in brackets) is as follows: P2Y 1 (ADP, ATP), P2Y 2 (UTP, ATP), P2Y 4 (UTP, ATP), P2Y 6 (UDP), P2Y 11 (ATP), P2Y 12 (ADP), P2Y 13 (ADP), and P2Y 13 (UDP glucose and other nucleotide sugars).…”